At least one claim relating to dosage of the drug was valid and infringed but the remainder were thrown out.
Actavis Group PTC EHF and others v Icos Corp and Eli Lilly & Co (Third Party) [2016] EWHC 1955 (Pat), 10 August 2016.
http://www.bailii.org/ew/cases/EWHC/Patents/2016/1955.html